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Summary
Neonatal exposure to Gross murine leukemia virus results in a profound inhibition of the virus-
specific T and B cell responses of adult animals. Animals exposed to virus as neonates exhibit
a marked depression in virus-specific T cell function as measured by the virtual absence of in
vivo delayed type hypersensitivity responses and in vitro proliferative responses to virally infected
stimulator cells. Further, serum obtained from neonatally treated mice failed to either immuno-
precipitate viralproteins or neutralize virus in an in vitro plaque assay, suggesting the concurrent
induction of a state of B cell hyporesponsiveness. The specificity of this effect at the levels of
both T and B cells was demonstrated by the ability ofneonatally treated mice to respond normally
after adult challenge with either irrelevant reovirus or influenza virus. The replication of Gross
virus within both stromal and lymphocytic compartments of the neonatal thymus suggests that
thymic education plays a key role in the induction ofimmunologic nonresponsiveness to viruses.
mmunologic nonresponsiveness to autologous molecules
and a variety of exogenous antigens can be linked to their
presence during neonatal maturation(1-4). The consequences
of neonatal exposure to viruses are considerably more vari-
able (5, 6). Mice infected either neonatally or congenitally
with lymphocytic choriomeningitis virus (LCMV)' or en-
dogenous ecotropic retroviruses mount potent Ig responses
and produce functional CTL precursors (7-9). However, several
recent studies have shown that exposure of neonatal mice to
Moloney murine leukemia virus significantly reduced the fre-
quency ofMoloney virus-specific CTL precursors and Ig levels
(6, 10). These contrasting results raise important questions
concerning the ability of different viruses to induce toler-
ance, and the contributions of T and B cell components to
virus-specific tolerance. To address these questions, the im-
mune response ofmice exposed as neonates to NB-tropic Gross
murine leukemia virus (GMuLV) was investigated. Exposure
of neonates to GMuLV induces a state ofimmunologic non-
responsiveness that may be linked to intrathymic replication
of this retrovirus.
1 Abbreviations used in this paper: DTH, delayed-type hypersensitivity;
GMuLV, Gross murine leukemia virus; HAU, hemagglutinating units;
LCMV,lymphocytic choriomeningitis virus; PFU, plaque-forming units;
RT, reverse transcriptase.
Intraperitoneal injection of neonatal mice with GMuLV
leads to the development of lymphatic leukemias typified by
the presence of thymic lymphomas, and to a unique form
ofpersistent infection within the central nervous system white
matter (11-13). The data reported here demonstrate that neo-
natal exposure to these murine retroviruses also induced a
state of virus-specific T cell nonresponsiveness, characterized
by impaired delayed type hypersensitivity and in vitro prolifer-
ative responses. Concomitant with this T cell defect was the
functional inactivation of virus-specific B cells, as evidenced
by the absence ofboth neutralizing and immunoprecipitating
antibody. These immunologic defects occur simultaneously
with the detection of GMuLV replication within thymic
stromal elements. The implication ofthese observations with
regard to more general aspects of immunologic tolerance is
discussed in the context ofthe specific requirements for viral
replication within thymic and lymphoid cells.
Materials and Methods
Mice .
￿
6-8-wk-old BALB/cByj mice (H-2d) were obtained from
TheJackson Laboratory, Bar Harbor, ME, and breeding pairswere
established. Mice were maintained on standard lab chow and water
and libitum. BALB/c nu/nu mice were obtained from the National
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at the University of Pennsylvania School of Medicine.
Viruses.
￿
Two strainsof GMuLV were used in these studies: pa-
rental NB tropic GMuLV and the WB91 strain of GMuLV (12).
Virus was expanded by passagein Sc-1 cells, a feral mouse embryo
fibroblast line (AmericanType Culture Collection, Rockville, MD).
Sc-1 cellswere grown in MEM supplemented with 10% FCSand
pre-treated with Polybrene(8 hg/ml) (Aldrich Chemical Co., Mil-
waukee, WI) for 1 hbefore addition of virus. To confirminfection
ofSc-1 cells, supernatants from confluent monolayers were tested
7-10 d aftervirus addition for the presence ofreverse transcriptase
(RT) according to the method of Goff et al. (14). Supernatants
were aliquoted and stored at -70°C. Viraltiters were determined
by a modified XC cell plaque assay (15).
Virus-specific neutralizing activity was determined by incuba-
tion of virus with medium (control) or test serum at a dilution
of1:5 for40 minat 37°C,followedby addition to Polybrene-treated
Sc-1 cells plated into six-well tissue culture plates (104 cells/well)
forXC cell plaque assay.Serumneutralizing activity was expressed
as a neutralization index, calculated as the difference in the logio
titer of the virus samples with or without serum.
The purified PR8 strain of influenza A virus was prepared and
quantitated for hemagglutinatinn activity by Dr. MichaelCancro
(University of Pennsylvania). Reovirus type 3 was prepared from
infected L cell monolayers as described previously (16).
Immunizations.
￿
Neonates were injected intraperitoneally with
2 x 103 plaque forming units (PFU) of live GMuLVcontaining
culture supernatants within the first 24 h afterbirth. At 6 wk of
age, these animals and age-matched controls were challenged in-
traperitoneally with 2 x 103 PFU of virus, and in some experi-
ments, with 1,000hemagglutinating units(HAU)of UV-inactivated
influenzavirus. Serumwascollectedby retro-orbital bleeding both
before and8 d after challenge. Samples were allowed to clot, spun
for 10 minutes in a micro-centrifuge, serum aspirated, and stored
at -20°C.
For delayed type hypersensitivity experiments, mice were im-
munized intraperitoneally at 6-8 wk of age with virus (2 x 103
retrovirus PFU or 3 x 106 reovirus PFU in 100 A1). All animals
were challenged after 6 d with 25 F.1 of virus in one footpad, and
25 Al of media in the contra-lateral footpad. 24 h later, footpad
swelling was measured in a blindmanner with a Fowler microm-
eter (Schelinger's, Brooklyn, NY). Responses were expressed as
the percentage increase in the thickness of the virally challenged
footpad as compared with the media challenged footpad.
RIA for Andinfuenza Antibody.
￿
Doubling dilutions of serum
were prepared in 20 mM sodium phosphate (pH 7.4), 0.02% so-
dium azide, 5% horse serum. 20 pl of either standard PR8-specific
hybridoma proteins or diluted serum was added to the wells of
microtiter plates (DynatechLaboratories, Inc., Alexandra, VA)pre-
viously coated with 20 HAU of purified virus. Antibody binding
to adsorbed virus was determined with affinity-purified, I'll-
labeled, goat antibody against mouse a, 'y, or A chains, or with
rabbit anti-mouse F(ab)z (kindly provided by Dr. Michael
Cancro).
Assayfor Virus-specific Serum Ig.
￿
Serumfrom mice treatedwith
GMuLVandWB91-GVwere assayedforvirus-specific Ig by binding
to thetumorcell linesKgvandKKC, respectively.Tumor cell lines
were originally derived from thymic lymphomas induced by in-
oculating adult BALB.K mice with these viruses (12, 17). Both
lines express viral proteins, including the envelope glycoprotein,
gp70, on their cell surface. 106 tumor cells were incubated for 45
min at 4°C with serum diluted 1:5 in 20 mM sodium phosphate
(pH 7.4), 1% BSA, 0.02% sodium azide (PBS-BSANaNs). Cells
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were washed twice and pellets were resuspended in 100 Al of a
1:100 dilution of a goat anti-mouse Ig/fluorescein conjugate (Fisher
Scientific Co., Pittsburgh, PA) andincubated at 4°C for 45 min.
As a positive control, tumor cells were first incubated with goat
anti-Rauscher gp70 antisera obtained from the Biological Carcino-
genesis Branch of theNational Cancer Institute, followed by arabbit
anti-goatIg/fluorescein conjugate.Cellsincubatedwithbuffer alone
followed by anti-mouse Ig/fluorescein served as a negative con-
trol. Cells were washed three times and resuspended in 500 A1 of
PBS-BSA-NaN3 andthen analyzed on a FACS IV flow cytometer
(BectonDickinson& Co., Mountain View, CA). Thedata areex-
pressed as thechangein mean channelfluorescenceofcellsincubated
with pre-challenge vs. that forcellsincubatedwith post-challenge
samples.
Surface Iodination of Tumor Cells.
￿
The membrane proteins of
tumor cells were surface labeled with Na115I as previously de-
scribed (18). Cellswere then incubatedwith 500A1 of lysisbuffer
(50mM tris, pH 7.6, containing 0.1% BSA, 300 mM NaCl, 1%
Triton X-100, 0.5% NP-40, 10 fag/ml leupeptin, 50 Wg/ml
aprotinin, 10 mM iodoacetamide, 0.4 mM sodium orthovanadate,
0.4 mM EDTA, 10 mM NaF, 10 mM sodium pyrophosphate, and
1 mM PMSF) and processed as described previously (IS). Lysates
were pre-cleared by incubating with protein A-Sepharose andthen
incubated with serum or purified goat anti-Rauscher gp70 at a
finaldilution of 1:10for45 min at 4°Cfollowed by the re-addition
of protein A-Sepharose. Pellets were resuspended in electropho-
resisloading buffer andanalyzed underreducing conditions by SDS-
PAGE and autoradiography.
Serum Immune Complex Assay.
￿
A solid phase assay designed
forthedetection of humanserumimmune complexes (Sigma Chem-
ical Co., St. Louis, MO) was adapted for measuring murine com-
plexes. Briefly, doublingdilutionsofnormal mouseserumor serum
from mice exposed to virus as neonates were prepared in 200 Al
of sample buffer. 5 Al of a solution containing -0.45-Wg equiva-
lents of humanimmune complexes permilliliter wasaddedto each
sample, and 100 AI of each was then transferred to microtiter wells
pre-coated with goat Clq and incubated at room temperature for
20 min. Wells were washed three times, after which 100 pl of a
goat anti-human Ig/alkaline phosphatase conjugatewas added and
incubated at room temperature for20 min. Wellswere againwashed
threetimes, 100 pl of substrate solution was added (p-nitrophenyl
phosphate, disodium hexahydrate, 1 mg/ml, pH 9.6), incubated
at room temperature for 20 min, and the reaction stopped by the
addition of 100Al of apH 12 alkaline solution. Absorbance at 405
nm wasmeasured with a microplate reader (Bio-Rad Laboratories,
Richmond, CA). This assay is sensitive to a serum immune com-
plex concentration corresponding to 20-wg equivalents/ml.
Detection of Tissue-deposited Immune Complexes.
￿
Kidneys from
6-8-wk-old neonatally treatedor normal mice were removed, placed
in TissueTek II OCT compound (LabTek Products, Naperville,
IL), and rapidly frozen. Frozen sections 3-4 Am in thickness were
cut, mountedon glass slides, andfixedin methanol (-20°C). Sec-
tions were incubated with a goat anti-mouse Ig/fluorescein con-
jugate (Fisher Scientific Co.) diluted 1:200 in 0.5 M Tris, pH 7.6,
for45 minat room temperature andwashed extensively. Slides were
analyzed on a Nikon Optiphot fluorescence microscope.
Mixed Lymphocyte Reaction.
￿
Enriched Tcell responderpopula-
tions were prepared by treating spleen cell suspensions with the
mAbs J11d (recognizes a determinant found on a variety of cell
types including amajority of B cells) and MKD6 (anti-I-Ad), and
amixture of guinea pig/rabbit complement. Stimulator cellswere
prepared from the spleens ofvirallyinfected animalsandirradiated
(3,000 rad). 5 x 105 respondercells were cocultured with 0.3 x105 to 106 stimulator cells in 96-well flat-bottomed microplates
(200 Al/well ofDMEM supplemented with 10% FCS, 5 x 10-1
M2-ME, 100U/ml penicillin, 100 Ag/ml streptomycin, and1mM
glutamine) . Cultures were maintained in a humidified atmosphere
containing 5% C02 at 37°C for 2 h, and were pulsed for the final
16 h with ['Hlthymidine (1.0 wCi/well) followed by harvesting
and counting.
Thymic Adherent CellLines.
￿
Thymic cell lines were established
from neonatal BALB/c mice injected with 2 x 103 PFU ofWB91-
GV at birth . After 10 d, thymi were removed, cells dissociated,
and the thymic capsule was incubated in 0.1% collagenase (Sigma
ChemicalCo .) in PBS for 20 min at 37°C . Cell lines were termed
NTgVCl and NTgVCl/T The cells were distributed in cell cul-
ture flasks in DMEM supplemented with 10% FCS, 2MM L-glu-
tamine, 5 x 10-5M 2-ME, modified Eagle's medium, nonessen-
tial amino acids, sodium pyruvate, and 1 mM Hepes buffer, and
maintained at high cell density for several weeks with periodic
removal of nonadherent cells . Stromal monolayers of mixed mor-
phology were evident at -3wk ofculture; in some cultures (NTgV
Cl/T), enrichment for epithelial cell populations was accomplished
by periodic removal of contaminating fibroblasts by brieftreatment
with Trypsin-EDTA (Gibco Laboratories, Grand Island, NY) .
Viral replication wasdetermined byRT assay as describedprevi-
ously (14) . Controls included culture supernatants from normal
d14 BALB/c primary fetal liver cell cultures, a thymic cortical re-
ticular epithelial cell line derived from SV40-transgenicmice desig-
nated 1308 .1 (182), or C57SV, an SV40-transformed embryonic
stromal cell line (19) .
Results
The Major Immunologic Response o ,f GMuLVinfected Mice
Is to thegp70 Envelope Glycoprotein. The antigenic specificity
of the humoral immune response of adult mice challenged
withGMuLV was initially evaluated by radioimmunoprecipi-
tation . To identify viral gene products, lysates of I'll surface-
labeled virus-induced tumor cells were first incubated with
purified goat Ig raised against the Rauscher virus glycopro-
tein. This reagent reacts with gp70 molecules encoded by
all murine leukemia viruses . As seen in Fig. 1, a band with
an apparent molecular weight of 70,000 was detected upon
incubation with immune goat serum (lane 2) compared with
normal goat serum (lane 1) . The Ig response ofnormal adult
mice to challenge withGMuLV displayed a similar specificity .
Figure 1. Immunoprecipitation of
gp70byGMuLV immune sera. Analysis
of antisera specificity was conductedby
immunoprecipitation of 1251-labeled
gp70-infectedKKC cells . Detergent cell
lysates were indirectly immunoprecipi-
tated with normal goat Ig (lane 1), goat
anti-Rauscher virus gp70 antiserum (lane
2), normal mouse serum (lane 3), or 8-d
post-bleed serum from an adultBALB/c
mouse challenged with 2 x 103PFUof
WB91-GV (lane 4) . Precipitates were
separated by 10% SDS-PAGE run under
reducing conditions and bands were de-
tected by autoradiography.
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Incubation of cell lysates with serum taken from a normal
6-wk-old BALB/c mouse 8 d after intraperitoneal injection
ofGMuLV resulted in the precipitation of a band of 70,000
(lane 4), compared with normal mouse serum (lane 3) . This
band was shown to correspond to the viral envelope glyco-
protein gp70 by successful pre-clearing of lysates with goat
anti-Rauscher gp70, before immunoprecipitation with mouse
serum (data not shown) . These results indicate that exposure
of normal adult BALB/c mice to intact GMuLV elicits a hu-
moral immune response directed predominantly against the
viral gp70 molecule . However, responses to other viral pro-
teins can be detected by this analysis. Over-exposure of the
same gels illustratedweak reactivityto proteins with apparent
molecular weights of 15,000, 30,000, and 43,000 . These bands
are believed to represent the viral proteins p15, p30, and gp43,
respectively (20) .
NeonatalExposure to GMuLVDiminishes the Ability ofAdult
Mice to Mounta Virus-specie Antibody Response. The effect
of neonatal exposure to GMuLV on adult immune respon-
siveness was determined byFACS analysis of serum Ig binding
to GMuLVinduced tumor cells. The exclusive detection of
gp70 in immunoprecipitates oftumor cells, as described above,
ensures that FACS analysis detects specific binding of retro-
virally encoded molecules . To assess the impact of neonatal
exposure to GMuLV, mice were intraperitoneally injected with
2 x 103 PFU of virus at 6-12 h after birth (these were
termed neonatally treated mice) or left untreated. Untreated
and neonatally treated mice were then challenged by in-
traperitoneal injection with 2 x 103 PFU ofGMuLV at 6-8
wk ofage . Serum samples obtained at pre- and post-challenge
were incubated withGMuWinfected tumor cells over a range
of serum dilutions to accurately assess antibody titer. Cells
were then incubated with a fluoresceinated goat anti-mouse
Ig conjugate, and subsequently analyzed by flow cytofluorom-
etry. Increases in the level of fluorescence between popula-
tions ofcells treated with equivalent dilutions ofpre- or post-
challenge sera reflect the level ofantibody molecules binding
viral proteins on the surface of these cells. As shown in Fig.
2 A, there was a 3.5-fold increase in staining ofcells incubated
with post-challenge serum compared with pre-immune serum .
In contrast, there was no detectable difference in stainingwhen
comparing cells incubated with pre- or post-challenge serum
from a neonatally treated mouse (Fig . 2 B) . A close compar-
ison of the FACS profiles ofpre-bleed sera for the two repre-
sentative animals shown in Fig. 2 also illustrates that the level
of endogenous (i .e., pre-challenge) antiviral antibody was de-
creased in neonatally treated mice.
A compilation ofFACS data from 10 mice treated and ana-
lyzed in an identical manner to that described in Fig . 2 is
shown in Fig. 3A. Normal mice produced significantly more
antibody in response to adult challenge with virus compared
with neonatally treated mice. These results are in marked con-
trast to previous observations with LCMV (7, 21), and to
studies conducted by one of us Q. Korostoff), on the effect
ofneonatal exposure to the PR8 strain of influenza virus (22) .
In this latter instance, neonatal exposure to influenza virus
induced a shift in the B cell repertoire without concomitant
reduction in the magnitude of the antibody response.L
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to GMuLV was examined by intraperitoneal challenge of mice
with PR8. These results (Fig. 3 B) indicate that mice treated
neonatally with GMuLV are fully capable of mounting a
normal influenza-specific humoral response. Normal mice had
U
c
d
H
A
d
V
G
W
fl!
Z
O a
Uf
W
OL
Log Green Fluorescence
to
O
ur
￿
UNTREATED NEO-TREATED
H
49
￿
TREATMENT
A
4
a 2.32-fold increase in antibody afterchallenge, while neona-
tally treated mice had a 2.34-fold increase in antibody levels.
Therefore, neonatal exposure to GMuLV resulted in a specific
decrease in the ability of mice to mountan antibody response
to subsequent adult challenge only with the same virus.
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Figure 2.
￿
Reduced binding ofserum from neo-
natally treated mice to gp70 on KKC cells. The
level of antibody to GMuLV antigens was evalu-
atedby FRCS analysis with KKC cells. Serum was
obtained from normal (A) or neonatally (B) treated
BALB/c mice before and 8 d after intraperitoneal
challenge with 2 x 103 PFU of WB91-GV KKC
cells were incubated with sera at a final dilution
of 1:5, then treated with fluoresceinated anti-Ig
reagents and analyzed on a FRCS IV flow cytom-
eter (Becton Dickinson & Co.).
SERUMSAMPLE
Figure 3.
￿
Mice treated with GMuLV as neonates have an impairment of virus-specific Ig production. Humoral immune response to GMuLV (A)
A compilation of FACS analyses of KKC cells incubated with serum from untreated (black bar) or neonatally treated (open bar) adult mice 8 d after
challenge with WB91-GV (n - 10). Data are expressed as the change in mean channel fluorescence of cells incubated with pre-challenge serum vs.
that for cells incubated with post-challenge samples. (*)_p < 0.05 by unpaired student's nest. Humoral response to the PR8 strain of influenza virus.
(B) Data obtained from RIA of serum from untreated
￿
lack bar) and GMuLV neonatally treated (open bar) adult mice 8 d after challenge with 1,000
HAU of influenza virus (n - 10). The data are expressed as the difference in cpm of 1251 bound between sera obtained before and after challenge.
The responses of these groups were not significantly different.
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￿
Serum from neonatally
treated mice does not immunopre-
cipitate or neutralize GMuLV Im-
munoprecipitations were conducted
as described in Fig. 1 . (A) The au-
toradiograph of 1251-labeled KKC
cell immunoprecipitates run on
10% SDS-PAGE. Lysates were im-
munoprecipitated with sera from
normal adult BALB/c mice chal-
lenged with WB91-GV (lanes 1 and
2), post-challenge sera ofneonatally
treated mice(lanes 3, 4, and 5), goat
anti-Rauscher virus gp70 antiserum
(lane 6), and normal mouse serum
(lane 7) . Analysis of the virus neu-
tralization activity of sera was de-
termined by direct inhibition of
plaque formation . (B) Pooled data
obtained from in vitro virus neutral-
ization assays performed on naive
mousesera (open bar), and sera from
neonatally treated (hatched bar) or
untreated (black bar) mice challenged
with WB91-GV Neutralization in
dices were calculated as the difference in the loglo titer ofGMuLV samples with or without serum . The neutralizing activity in the serum of normal
mice after GMuLV challenge was significantly greater than that of serum from neonatally treated mice; (*)p < 0.005 . The neutralization indices deter-
mined for neonatally treated and naive mice were not significantly different .
Previous studies by Oldstone and colleagues (7, 8, 21) have
shown that virus-specific antibody may pass undetected due
to the sequestration of antibody in the form of circulating
or tissue-deposited immune complexes . To address this pos-
sibility, the serum and kidneys of mice were examined for
the presence ofimmune complexes, in a manner similar to
that described in the LCMV system. There were no detect-
able differences in the levels ofcirculating or tissue-deposited
immune complexes when comparing normal adult mice with
neonatally treated mice rechallenged with GMuLV as adults
(data not shown) .
Neonatally Treated Animals Lack both Immunoprecipitating
and Neutralizing Antibody Responses. The observation that
neonatally treated mice exhibited reduced levels of virus-specific
antibody prompted analysis of the physiological significance
of this hyporesponsiveness. Representative serum samples were
first analyzed for their ability to precipitate viral proteins from
lysates of GMuLVinfected cells. As seen in Fig. 4 A, sera
from normal adult mice challenged with virus (lanes 1 and
2) contained antibody capable of Immunoprecipitating gp70
from cell lysates. In contrast, sera from neonatally treated mice
(lanes 3, 4, and S) failed to immunoprecipitate gp70 or any
other viral proteins under the same conditions. Similar im-
munoprecipitation analysis of tumor cell lysates that were
metabolically labeled with 35S-methionine also failed to de-
tect any response to viral proteins (data not shown) . This
observation shows that the humoralimmune response ofmice
exposed to GMuLV as neonates is not redirected towards a
nonenvelope viral antigen .
Serum samples were also tested for their ability to neu-
tralize infectious virus by in vitro plaque-forming assays. As
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seen in Fig. 4 B, sera from normal adult mice (untreated)
challenged with GMuLV contained substantial neutralizing
activity. These sera were significantly more effective at neu-
tralizing the virus compared with sera from neonatally treated
or naive normal mice, which showed no neutralizing activity.
Taken together, these results indicate that exposure of mice
to virus as neonates totally abrogates their ability to produce
physiologically relevant virus-binding or neutralizing anti-
body in response to adult challenge with GMuLV .
Nude MiceDo NotMount Normal Humoral Responses to Chal-
lenge with GMuLV To determine the role ofT cells in the
generation of normal anti-Gross virus-specific humoral re-
sponses, 6-8-wk-old normal BALB/c or male BALB/c nu/nu
mice were intraperitoneally injected with GMuLV on days
0 and 8, and bled on days 0, 8, and 16 . The serum samples
obtained from these bleeds were analyzed for the presence
ofGMuLVspecific antibody, and for the ability to neutralize
virus in the in vitro plaque assay. Although nude mice did
mount a virus-specific antibody response to GMuLV chal-
lenge, the kinetics as well as the magnitude of this response
were markedly different from that seen in normal mice (Fig .
5A) . A large amount of antivirus antibody could be detected
in the sera of normal mice 8 d after primary exposure, and
this activity increased to amaximum level at 8 d post-secondary
challenge. In contrast, sera from nude mice contained con-
siderably less GMuLVspecific antibody after primary exposure,
and failed to show any signs ofa secondary response. A marked
difference was also detected when the function ofanti-GMuLV
antibodies in nude mice was examined (Fig. 5 B). Ig from
nude mice was incapable of neutralizing infectious virus,
whereas the response of normal mice displayed potent neu-LL
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tralizing activity. These results suggest that T cells play an
important role in the generation of a physiologically normal
anti-GMuW response, and that the impaired humoral response
seen in neonatally treated mice may be related to a form of
T cell nonresponsiveness.
Neonatally Treated Mice Have Impaired Virus-specific T Cell
Function. To address the effect of neonatal exposure to virus
on subsequent T cell responsiveness, delayed type hypersen-
sitivity (DTH) responses to GMuLV challenge were deter-
mined. The DTH response provides a reliable measure of in
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Figure 5.
￿
Nude mice have impaired humoral responses
to GMuM Serum Ig responses were determined by FACS
analysis as described in Fig. 2. (A) The FACS analysis of
serum obtained from normal and nude mice 8 d after pri-
mary (black bar) and secondary (open bar) intraperitoneal
challenge with 2 x 10; PFU of WB91-GV. The sec-
ondary responses ofnormal micewere significantly greater
than those of nude mice; (*) p < 0.02. Sera were also
analyzed for the presence ofneutralizing antibody as de-
scribed in Fig. 4. (B) The neutralizing activity of serum
from naive mice, immune BALB/c mice (normal BALB/c
mice 8 d after virus challenge), naive nude mice, and im-
mune nude mice (nude mice 8 d after viral challenge).
The neutralizing activity in the serum of normal mice
after virus challenge was significantly greater than that
ofserum from virally challenged nude mice; (*)p <0.002.
vivo Th cell function. Normal or neonatally treated BALB/c
mice were intraperitoneally injected with GMuLV, and after
6 d, animals were challenged by paired footpad injection with
either virus or media. DTH responses were measured 24 h
later. The data in Fig. 6 A illustrate a significant decrease
in the magnitude of DTH responses elicited in neonatally
treated mice compared with that of normal mice. The
specificity ofthis inhibition was demonstrated by normal DTH
responses in the same mice to antigenically irrelevant reo-
virus (Fig. 6 B).E
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Figure 6.
￿
Neonatal exposure to GMuLV abolishes virus-specific DTH
responses. DTH reactionsofuntreated and neonatally treated BALB/c mice
were measured by a footpad swelling assay. (A) Untreated (black bar) or
neonatally treated (open bar) mice were immunized intraperitoneally with
2 x 103 PFU of WB91-GV and were rechallenged 6 d later by paired
footpad injection with either virus or media. Footpad swelling was mea-
sured after 24 h. The response of these same mice to subsequent challenge
with 3 x 106 PFU of reovirus is shown in B. The response of untreated
mice to GMuLV was significantly greater than that of neonatally treated
mice; (*)p < 0.001. The response ofneonatally treated mice was not statisti-
cally significant compared with background. The responses of reovirus
immunized mice were not significantly different.
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As a more direct measure ofisolated T cell activity, in vitro
proliferative responses ofenriched T cell populations prepared
from the spleens ofnormal and neonatally treated mice were
measured. Antigen-primed T cells were cocultured with syn-
geneic, GMuLVinfected, or uninfected spleen cells for 48 h.
[3H]Thymidine was added for the last 16 h of culture, after
which cells were harvested and the counts incorporated de-
termined. Data shown in Table 1 demonstrate a significant
diminution in the GMuLV proliferative response of enriched
T cells from neonatally exposed mice compared with that
ofcells from normal mice. Thus, neonatal exposure to GMuLV
induces a stateof severe T cell nonresponsiveness in adult mice.
Thymic Stromal Cells Support the Replication ofGMuLV In
Viva Previous work has shown that GMuLV infects cells
of lymphoid origin within the thymus (23, 24). Replication
of virus within nonlymphoid thymic cells was investigated
by measuring RT activity in supernatants from adherent cell
linesestablished from the thymi ofmice infected with GMuLV
at birth. As shown in Table 2, significant levels of RT ac-
tivity were detected in the supernatants of two such cell lines:
NTgVCl and NTgVCl/T Both lines were enriched for thymic
stromal cells. NTgVCl/T was further enriched for thymic
epithelial cells. RT activity was not detected in supernatants
from uninfected cell lines, including 1308.1, a thymic cor-
ticalreticular epithelial cell line. lmmunohistochemical anal-
ysis of the adherent stromal cell cultures showed that 25-30%
of these cells expressed viral gp70 on their cell surface, and
that these cells were of a CD4- /CD8 - /CD3 - phenotype
Table 1 .
￿
GMuLVprimed T Cells Fail to Proliferate in
Response to Coculture With Virally Infected
Syngeneic Splenocytes
[3H]TdR incorporation
Pooled antigen-primed T cells were prepared from the spleens of either
normal or neonatally treated BALB/c mice 2 wk after intraperitoneal
challenge with 2 x 103 PFU of GMuLV. Normal responders alone in-
corporated 3,165 cpm and neonatally treated responders incorporated,
3,673 cpm (means of triplicate samples) .
' The data represent mean values of [3H]TdR incorporation of 12
samples.
t Virus-specific response was calculated as: response to GMuLV infected
splenocytes minus response to normal splenocytes.
S The virus-specific proliferative response of cells from normal donors
was significantly greater than that ofcells from neonatally treated animals
(p < 0.05) as determined by F test statistics .
Normal mice
cpm
Neonatally
treated mice
Normal splenocytes" 3,493 3,741
GMuLV-infected splenocytes" 5,502 3,689
Virus-specific response# 1,829 OS
Con A 28,924 41,978Discussion
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(data not shown). Greater than 95% of cells from both lines
reacted with a mAb (ERTR5) that exclusively detects thymic
medullary epithelialcells (data not shown). These data indi-
cate that GMuLV infects and subsequently replicates in non-
lymphoid thymic stromal cells.
Analyses of multiple parameters of B and T cell function
showed that neonatal exposure of mice to GMuLV dramati-
cally altered immune responses to adult challenge with this
virus. Exposure ofnaive BALB/c mice to GMuLV at 6-8 wk
of age stimulated a vigorous anti-Gross virus humoral re-
sponse. The predominant response was towards the viral gly-
coprotein, gp70, as detected by immunoprecipitation from
lysates ofradiolabeled GMuLVinduced tumor cells. The an-
tibody molecules generated are potent at neutralizing infec-
tious virus. It is interesting to note that the antiretrovirus
immune response in a naive adult mouse does not necessarily
protect an animal from virus infection. Upon immunization
with parental GMuLV, BALB/c-H-2k (BALB.K) mice de-
velop a persistent infection despite the generation of virus-
neutralizing antibody (25) . The basis of this appears to lie
with the development of variant viruses that differ within
the neutralization-sensitive epitopes expressed on the gp70
molecule. The result of these antigenic variations is that
BALB.K mice do not generate an effective antiviral immune
response. Preliminary studies suggest that similar types of
variants arise in BALB/c and BALB/c-H-26 (BALB.B) mice.
In contrast to the response of naive adult mice, the sera
of identically immunized but neonatally treated mice, con-
tain barely detectably levels of antiviral antibody by direct
binding analysis, and were not capable of either precipitating
viral proteins or neutralizing infectious virus. This effect is
antigen specific in that neonatally treated animals exhibited
normal humoral responses to influenza virus. The inability
to detect normal levels of antiviral antibody in neonatally
treated mice was not due to the formation of circulating serum
or tissue-deposited immune complexes.
' Data represent mean and SEM of 32P-TTP incorporation of duplicate samples.
# These values are significantly different from the media control (p < 0.001), as determined by the student's t test.
Immunologic Nonresponsiveness to Murine Retroviruses
These observations demonstrate that the low levelof anti-
body in the serum of hyporesponsive, neonatally treated
animals are of extremely low affinity and are therefore oflittle
physiologic relevance. This hypothesis is supported by prior
descriptions of the presence oflow affinity tolerogen-binding
antibody in naturally occurring and experimentally induced
models of immunologic nonresponsiveness (26, 27). These
observations also bear on the presence of endogenous anti-
MuLV antibody (20, 28). GMuLV crossreactive antibody is
present in the serum of naive, normal mice but was not de-
tected in the neonatally treated mice, indicating that neo-
natal exposure to GMuLV also abrogates the ability to re-
spond to related endogenous MuLVs. The presence of
anti-GMuLVspecific antibody in AKR mice (8), which en-
dogenously express this virus, seems to argueagainst this hy-
pothesis. However, the presence of maternally transmitted
virus-specific antibody and low level of endogenous virus
production in newborn AKR mice (29) probably preclude
the development of neonatal tolerance.
The B cell hyporesponsiveness seen in neonatally treated
mice can be explained by a number of mechanisms, all of
which have been demonstrated experimentally by others. Pos-
sibilities include the physical elimination (30) or functional
silencing of antigen-reactive B cell clones (31, 32). Determi-
nation of the frequency of anti-GMuLVspecific B cell pre-
cursors by limiting dilution analysis in normal and neona-
tally treated mice would resolve this issue. However, the
presence oflow but detectable levels of antiviral antibody in
the serum of some neonatally treated animals argues against
the absolute deletion or silencing of reactive clones in our
system. A more likely hypothesis is that B cell hyporespon-
siveness is linked to the abrogationof GMuLVspecific T cell
function. For example, it has recently been reported that B
cell nonresponsiveness in transgenic mice expressing a vesic-
ular stomatitis virus cell membrane-associated glycoprotein
is dependent on the loss of T cell help (33).
To address this possibility, the role of T cellsin the gener-
ation of a physiologically normal anti-GMuLV antibody re-
sponse was first determined. These studies showed that nude
Table 2. Replication ofGMuLV in
Cell type
Thymic Stromal Cells
Description RT activity
cpm
Media 135 ± 33`
Kgv GMuLV-induced T lymphoma 4,677 ± 270
NTgV-C1 Mixed thymic stromal cells 1,449 ± 6r
NTgV-C1/T Enriched thymic epithelial cells 1,068 ± 15t
Fetal Liver Primary culture from normal day 14 embryos 43 ± 11
1308.1 SV40-transformed thymic cortical reticular 80±7
epithelial cell line
C57.SV SV40-transformed embryonic stromal cell line 62 ± 11mice failed to express typical levels of neutralizing antibody
and secondary responses after GMuLV challenge, analogous
to the response of neonatally treated mice. The inability of
serum from nude mice to either neutralize infectious virus,
or immunoprecipitate viral antigens (J. Korostoff, unpublished
data), suggests that these antibodies are of low affinity, and
most likely of the 1A isotype. The weak antibody responses
of nude and neonatally treated mice may therefore be due
to direct activation of B cells recognizing T cell-indepen-
dent epitopes within the structure of the gp70 molecule. A
similar model was previously described for the nucleocapsid
antigen of Hepatitis B virus (34).
The requirement for virus-specific T cell help in the gener-
ation of a normal anti-GMuLV antibody response lead to di-
rect analysis of the effect of neonatal exposure to GMuLV
on CD4+ T cell function. It has been previously shown that
neonatal exposure to Moloney murine leukemia virus resulted
in severe reduction in the frequency ofprecursors to virus-
specific cytotoxic (CD8+) T cells (10). In this regard,
GMuLVspecific DTH and in vitro proliferative responses were
determined. Neonatally treated mice did not show a significant
DTH response after challenge with GMuLV, despite normal
responses of the same mice to antigenically irrelevant reo-
virus. Further, enriched T cells prepared from the spleens of
neonatally treated mice failed to show any proliferative re-
sponse to GMuLVinfected syngeneic splenocytes despite
normal responses to Con A. The observation of antigen-
specific CD4+ T cell nonresponsiveness supports the hy-
pothesis that B cell hyporesponsiveness is a reflection of the
absence of T cell help (32, 33, 35).
Recent work from a number of laboratories has shown
that T cells can be rendered nonresponsive by intrathymic
clonal abortion (36, 37), functional inactivation (38), or the
induction ofperipheral immunoregulatory phenomena such
as suppressor T cells (39). The data presented here do not
allow us to define the mechanism operative in this system.
However, by determining the frequency of precursors to
GMuLVspecific CD4+ T cells, as well as studying the
effects of adoptive transfer of cells from neonatally treated
mice on the immune competence of normal recipient mice,
it will be possible to elucidate the events leading to the T
cell nonresponsiveness seen afterneonatal exposure to GMuLV
Although our data agree with the results ofothers regarding
the induction of neonatally induced nonresponsiveness to
retroviruses (10, 40, 41), other systems have been described
in which neonatal or congenital exposure to virus does not
altervirus-specific immune responsiveness. The most notable
example is LCMV Oldstone and colleagues (reviewed in ref-
erence 21) have shown that mice persistently infected with
LCMVfrom birth produce similar amounts of antibody with
the same specificities to that found in normal LCMV im-
mune mice. However, most of the antiviral antibody in per-
sistently infected mice was sequestered in the kidneys in the
form of immune complexes. Jamieson and Ahmed (9) have
also shown that persistently infected animals are capable of
mounting antiviral cytotoxic T cell responses after adoptive
immunotherapy to reduce the viralload, suggesting that the
precursors to these cells are neither clonally deleted nor irre-
versibly inactivated. Why then does one type of virus, e.g.,
GMuLV, induce immunologic nonresponsiveness, while an-
other, e.g., LCMV, does not?
It is commonly accepted that the thymus is intimately in-
volved in the induction of T cell nonresponsiveness to self-
antigens. Therefore, it follows that the more efficient a mol-
ecule is at reaching (and subsequently being processed and
presented in) the thymus, the more potent its tolerogenic effect.
The analysis of stromal cell lines derived from the thymi of
mice neonatally infected with GMuLV showed infection and
replication of virus within nonlymphoid cells of the thymus
(Table 2). GMuLV also appears to infect cells at many stages
along the T cell differentiation pathway, including the
CD4 - /CD8 - precursors that give rise to functionally ma-
ture T cells (24). Preliminary results from our laboratory in-
dicate that at 8 d of age, 5% of thymocytes isolated from
neonatally treated mice are infected with GMuLV. This in-
creases to 17% by 3 mo of age. The dual tropism for lym-
phoid and nonlymphoid thymic cellular compartments allows
rapid accumulation ofGMuLV within thymic cells, some of
which are intimately involved in shaping the T cell reper-
toire. The continuous productionofGMuLV throughout the
life of a neonatally infected mouse would serve to maintain
the nonresponsive stateby peripheral inactivation of any high
affinity antiviral-specific lymphocytes that escaped tolerance
induction (42, 43).
The presence of LCMVspecific antibody in congenitally
and neonatally infected mice can be explained in a reciprocal
fashion. LCMV infects mature peripheral CD4+ T cells
(44), and would therefore be predicted to be far less efficient
at accumulating in the thymus compared with viruses that
infect cells early in the T cell differentiation pathway. It has
been shown that <1% of thymocytes from 6-mo-old LCMV
carrier mice are actively infected with virus (45). There is
no evidence ofLCMVinfection ofthymic stromal elements.
Recently, it has been demonstrated that neonatally infected
transgenic mice delete CD4+/CD8+ thymocytes that bear
a high affinity anti-LCMV TCRa/f3 (46). The work ofothers
indicates, however, that the low level of intrathymic LCMV
infection is insufficient to physically eliminate the majority
of LCMVspecific T cells (7, 9, 21). To determine the validity
of this model, we are currently analyzing thymocytes and
stromal cell lines derived from neonatally infected mice to
more accurately quantitate the rate of accumulation of viral
material within the thymus. Cloning of GMuMnfected thymic
stromal cell lines is also in progress in order to determine
the phenotypic characteristics and functional properties of
these cells.
We thank Dr. Allan Pickard for performing flow cytofluorometric analyses, Dr. M. B. A. Oldstone for
his comments on immune complex deposition, and Joanne Pratt for critical review of the manuscript.
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